| Name: | Azilsartan K Medoxomil Impurity-6 |
| Catalogue No. | VL252006 |
| CAS No. | 1417576-00-1 |
| Molecular Formula | C28H20N4O8 |
| Molecular Weight | 540.48 |
| Status | In-stock |
| IUPAC Name | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-hydroxy-1-((2’ -(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1’ -biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
| Synonyms | Azilsartan Medoxomil Desethyl Impurity |
| Description | Azilsartan K Medoxomil Impurity 6/Azilsartan Medoxomil Desethyl Impurity(CAS No: 1417576-00-1) or (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-hydroxy-1-((2’ -(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1’ -biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate,it belongs to angiotensin receptor blockers class, is used to treat high blood pressure. |
| References | Pradhan, Akshyaya, et al. “Azilsartan: Current Evidence and Perspectives in Management of Hypertension.” International Journal of Hypertension, vol. 2019, 3 Nov. 2019, pp. 1–8, 10.1155/2019/1824621. Accessed 17 Aug. 2021. |
